---
title: "American Cannabis Company, Inc. SEC 10-Q Report"
date: "2025-02-12 00:13:01"
summary: "American Cannabis Company, Inc., a prominent player in the cannabis industry, has released its Form 10-Q report for the third quarter of 2023. The report outlines significant financial and operational challenges faced by the company, including a notable decline in revenues and increased operational losses. Despite these hurdles, the company..."
categories:
  - "TradingView"
lang:
  - "en"
translations:
  - "en"
tags:
  - "TradingView"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

American Cannabis Company, Inc., a prominent player in the cannabis industry, has released its Form 10-Q report for the third quarter of 2023. The report outlines significant financial and operational challenges faced by the company, including a notable decline in revenues and increased operational losses. Despite these hurdles, the company remains focused on securing additional financing to support its growth and operational needs.

**Financial Highlights**

* **Total Revenues**: $0.69 million, reflecting a decrease of $0.88 million compared to the same period in 2023 due to reduced consulting and product sales.
* **Gross Profit**: $(0.20) million, a decrease from $0.64 million in the prior year, primarily due to inventory obsolescence adjustments.
* **Loss from Operations**: $(0.69) million, compared to $(0.57) million in the previous year, indicating a slight increase in operational losses.
* **Net Loss**: $(0.77) million, an increase from a net loss of $(0.46) million in the same period last year, driven by higher interest expenses and reduced revenues.
* **Net loss per common share â€“ basic and diluted**: $(0.00), consistent with the prior year, reflecting the impact of increased shares outstanding.

**Business Highlights**

* **Revenue Segments**: The company experienced a significant decrease in consulting service revenues, which fell to $29,958 from $468,500, and product and equipment revenues, which decreased to $104,389 from $737,759. This decline is attributed to market saturation, increased competition, and reduced demand for products and consulting services.
* **Cannabis Product Performance**: Cannabis product revenues increased to $553,252 from $358,856, indicating a growth in the retail cannabis market. However, the cost of cannabis products also rose significantly, reflecting adjustments for inventory obsolescence.
* **Operational Efficiency**: The company achieved a reduction in the cost of revenues by $37,210, primarily due to improved efficiencies in the cultivation process and streamlined operations, which enhanced operational efficiencies and reduced costs.
* **Consulting Services**: The demand for consulting services has been unpredictable, driven by evolving regulations and a highly competitive market, leading to a decrease in consulting service revenues.
* **Future Outlook**: Management is focused on securing additional financing to support operations and growth, with expectations that the transaction with TEC, LLC will provide necessary funding to complete reporting obligations and advance regulatory applications.

SEC Filing: [American Cannabis Company, Inc. [ AMMJ ] - 10-Q - Feb. 11, 2025](https://www.sec.gov/Archives/edgar/data/945617/000190359625000076/f2s10q.htm)

[TradingView](https://www.tradingview.com/news/tradingview:928325d011132:0-american-cannabis-company-inc-sec-10-q-report/)
